DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

Ausgabe 01 · Volume 51 · Februar 2025 DOI: 10.1055/s-015-60961 Advances in the Management of Hemophilia and Bleeding Disorders: Achievements and Perspectives Guest Editors: Antonio Coppola, MD, and Massimo Franchini, MD

Publisher's Note

  • 001
  • Preface

  • 002
  • Editorial

  • 005
  • Review Article

  • 010
    Coppola, Antonio; Zani, Matteo; Quintavalle, Gabriele; Focosi, Daniele; Franchini, Massimo:

    The Evolution of Hemophilia Pharmacological Treatments and Therapeutic Targets at the Turn of the Third Millennium

  • 018
  • 023
  • 028
  • 041
  • 049
  • 058
    Dolan, Gerard; Fijnvandraat, Karin; Lenting, Peter J.; Catarino, Cristina; Lavin, Michelle; on behalf of the Factor Think Tank:

    Nonsevere Hemophilia: The Need for a Renewed Focus and Improved Outcomes

  • 068
  • 073
    Giuffrida, Anna C.; Siboni, Simona M.; Baronciani, Luciano; Poli, Giovanni; Gandini, Giorgio; Peyvandi, Flora:

    Emicizumab in Type 3 von Willebrand Disease: Report of a Case with an Alloantibody and Literature Review

  • 081
  • 091
    Cerrone, Antonio; Buscarini, Elisabetta; Berté, Roberto; Alicante, Saverio; Bertolazzi, Stefania; Moreschi, Olivia; Griffanti, Paola; Manfredi, Guido:

    Hereditary Hemorrhagic Telangiectasia: On the Brink of a New Treatment Era?